BridgeBio Pharma Inc (BBIO)
34.61
+1.59
(+4.82%)
USD |
NASDAQ |
Apr 02, 16:00
34.61
0.00 (0.00%)
After-Hours: 20:00
BridgeBio Pharma Total Liabilities (Quarterly): 2.377B for Dec. 31, 2024
View 4,000+ Financial Data Types:
Add
Browse
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Alnylam Pharmaceuticals Inc | 4.173B |
| Pfizer Inc | 124.90B |
| Catalyst Pharmaceuticals Inc | 123.78M |
| Plus Therapeutics Inc | 15.58M |
| Insmed Inc | 1.740B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 919.34M |
| Shareholders Equity (Quarterly) | -1.468B |
| Debt to Equity Ratio | -1.173 |
| Current Ratio | 4.668 |
| Net Debt Paydown Yield | -0.00% |